The treatment of postprandial hypotension in autonomic failure with 3,4- dl-threo-dihydroxyphenylserine

Neurology

Volumn 47, Issue 6, 1996, Pages 1414-1420

  Freeman, Roy ^a,c   Young, James ^d   Landsberg, Lewis ^d   Lipsitz, Lewis ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b RESEARCH AND TRAINING INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN DERIVATIVE; THREO 3,4 DIHYDROXYPHENYLSERINE;

ADRENERGIC TRANSMISSION; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; HYPOTENSION; MALE; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHY DRAGER SYNDROME; VASCULAR RESISTANCE;

EID: 0029774180     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.6.1414     Document Type: Article

References (39)

1. Robertson D, Wade D, Robertson RM. Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunction states. Am J Cardiol 1981;48:1048-1052.
2. Lipsitz LA, Nyquist RP Jr, Wei JY, Rowe JW. Postprandial reduction in blood pressure in the elderly. N Engl J Med 1983;309:81-83.
3. Mathias CJ. Postprandial hypotension: pathophysiological mechanisms and clinical implications in different disorders [clinical conference]. Hypertension 1991;18:694-704.
4. Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995;122:286-295.
5. Lipsitz LA, Pluchino FC, Wei JY, Minaker KL, Rowe JW. Cardiovascular and norepinephrine responses after meal consumption in elderly (older than 75 years) persons with postprandial hypotension and syncope. Am J Cardiol 1986;58: 810-815.
6. Hakusui S, Sugiyama Y, Iwase S, et al. Postprandial hypotension: microneurographic analysis and treatment with vasopressin. Neurology 1991;41:712-715.
7. Ryan SM, Goldberger AL, Ruthazer R, Mietus J, Lipsitz LA. Spectral analysis of heart rate dynamics in elderly persons with postprandial hypotension. Am J Cardiol 1992;69:201-205.
8. Lipsitz LA, Ryan SM, Parker JA, Freeman R, Wei JY, Goldberger AL. Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation 1993;87:391-400.
9. Freeman R, Landsberg L. The treatment of orthostatic hypotension with dihydroxyphenylserine. Clin Neuropharmacol 1991;14:296-304.
10. Ziegler MG, Lake CR, Kopin IJ. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 1977;296:293-297.
11. Goldstein DS, Polinsky RJ, Garty M, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 1989;26:558-563.
12. Polinsky RJ. Clinical autonomic neuropharmacology. Neurol Clin 1990;8:77-92.
13. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46:1470.
14. Freeman R, Roberts M, Landsberg L. The treatment of neurogenic orthostatic hypotension with DL-dihydroxylphenylserine. Clin Auton Res 1992;2:66.
15. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond) 1953;121:1-27.
16. Williams M, Young JB, Rosa RM, Gunn S, Epstein FH, Landsberg L. Effect of protein ingestion on urinary dopamine excretion: evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man. J Clin Invest 1986;78:1687-1693.
17. Kooner JS, Raimbach S, Watson L, Bannister R, Peart S, Mathias CJ. Relationship between splanchnic vasodilation and postprandial hypotension in patients with primary autonomic failure. J Hypertens Suppl 1989;7:S40-S41.
18. Raimbach SJ, Cortelli P, Kooner JS, Bannister R, Bloom SR, Mathias CJ. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes. Clin Sci 1989;77:623-628.
19. Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kingaid D, Robertson D. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 1985;313:549-554.
20. Mathias CJ, da Costa DF, Fosbraey P, et al. Cardiovascular, biochemical and hormonal changes during food-induced hypotension in chronic autonomic failure. J Neurol Sci 1989;94: 255-269.
21. Jansen RW, Hoefnagels WH. The influence of oral glucose loading on baroreflex function in the elderly. J Am Geriatr Soc 1989;37:1017-1022.
22. Potter JF, Heseltine D, Hartley G, Matthews J, Macdonald IA, James OF. Effects of meal composition on the postprandial blood pressure, catecholamine and insulin changes in elderly subjects. Clin Sci 1989;77:265-272.
23. Waaler BA, Eriksen M, Toska K. The effect of meal size on postprandial increase in cardiac output. Acta Physiol Scand 1991;142:33-39.
24. Hirayama M, Watanabe H, Koike Y, et al. Postprandial hypotension: hemodynamic differences between multiple system atrophy and peripheral autonomic neuropathy. J Auton Nerv Syst 1993;43:1-6.
25. Brown RT, Polinsky RJ, Baucom CE. Euglycemic insulin-induced hypotension in autonomic failure. Clin Neuropharmacol 1989;12:227-231.
26. Bartholini J, Constantinidis J, Puig M, Tissot R, Pletscher A. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. J Pharmacol Exp Ther 1975;193:523-532.
27. Mathias CJ. Effect of food intake on cardiovascular control in patients with impaired autonomic function. J Neurosci Methods 1990;34:193-200.
28. Hoeldtke RD, Dworkin GE, Gaspar SR, Israel BC, Boden G. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension. Am J Med 1989;86:673-677.
29. Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Neurology 1988;38:1091-1094.
30. Kaufmann H, Oribe E, Yahr MD. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure. J Neural Transm Park Dis Dement Sect 1991;3:143-148.
31. Hoeldtke RD, Boden G, O'Dorisio TM. Treatment of postprandial hypotension with a somatostatin analogue (SMS 201-995). Am J Med 1986;81:83-87.
32. Jansen RW, Peeters TL, Lenders JW, Van Lier HJ, v't Laar A, Hoefnagels WH. Somatostatin analog octreotide (SMS 201-995) prevents the decrease in blood pressure after oral glucose loading in the elderly. J Clin Endocrinol Metab 1989;68:752-756.
33. Hoeldtke RD, Davis KM, Joseph J, Gonzales R, Panidis IP, Friedman AC. Hemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 1991;84:168-176.
34. Hoeldtke RD, Israel BC. Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 1989;68:1051-1059.
35. Heseltine D, Dakkak M, Woodhouse K, Macdonald IA, Potter JF. The effect of caffeine on postprandial hypotension in the elderly. J Am Geriatr Soc 1991;39:160-164.
36. Lipsitz LA, Jansen RW, Connelly CM, Kelley-Gagnon MM, Parker AJ. Haemodynamic and neurohumoral effects of caffeine in elderly patients with symptomatic postprandial hypotension: a double-blind, randomized, placebo-controlled study. Clin Sci 1994;87:259-267.
37. Hoeldtke RD, O'Dorisio TM, Boden G. Prevention of postprandial hypotension with somatostatin. Ann Intern Med 1985; 103(pt 1):889-890.
38. Hirayama M, Watanabe H, Koike Y, et al. Treatment of postprandial hypotension with selective alpha 1 and beta 1 adrenergic agonists. J Auton Nerv Syst 1993;45:149-154.
39. Hoeldtke RD, Cavanaugh ST, Hughes JD, Polansky M. Treatment of orthostatic hypotension with dihydroergotamine and-caffeine. Ann Intern Med 1986;105:168-173.